Role of secretory phospholipases in atherogenesis (Q37167790)

18 August 2017

1 reference

title

Role of secretory phospholipases in atherogenesis (English)

1 reference

18 August 2017

Ann-Cathrine Jönsson-Rylander

1

1 reference

18 August 2017

Sofia Lundin

2

1 reference

18 August 2017

Birgitta Rosengren

3

1 reference

18 August 2017

Camilla Pettersson

4

1 reference

18 August 2017

Eva Hurt-Camejo

5

1 reference

18 August 2017

1 June 2008

1 reference

Current Atherosclerosis Reports

18 August 2017

1 reference

18 August 2017

10

1 reference

18 August 2017

3

1 reference

18 August 2017

252-259

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-008-0039-6

18 August 2017

0 references

cites work

The phospholipase A2 superfamily and its group numbering system

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0039-6

Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0039-6

Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0039-6

Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0039-6

Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0039-6

Structure, function, and regulation of group V phospholipase A(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0039-6

Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0039-6

Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human

21 January 2018

1 reference

12 December 2020

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

1 reference

12 December 2020

Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis

1 reference

12 December 2020

Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism

1 reference

12 December 2020

Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction.

1 reference

12 December 2020

Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model

1 reference

12 December 2020

Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2

1 reference

12 December 2020

Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits

1 reference

12 December 2020

Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2).

1 reference

12 December 2020

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

1 reference

12 December 2020

The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2

1 reference

12 December 2020

Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis

1 reference

12 December 2020

Different functional aspects of the group II subfamily (Types IIA and V) and type X secretory phospholipase A(2)s in regulating arachidonic acid release and prostaglandin generation. Implications of cyclooxygenase-2 induction and phospholipid scramb

1 reference

12 December 2020

Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5 , shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study

1 reference

12 December 2020

Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function.

1 reference

12 December 2020

Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset

1 reference

12 December 2020

Computational analysis of the membrane association of group IIA secreted phospholipases A2: a differential role for electrostatics

1 reference

12 December 2020

Potential involvement of type II phospholipase A2 in atherosclerosis

1 reference

12 December 2020

CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up

1 reference

12 December 2020

Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model

1 reference

12 December 2020

Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity

1 reference

12 December 2020

Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation

1 reference

12 December 2020

Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile

1 reference

12 December 2020

Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions

1 reference

12 December 2020

Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells

1 reference

12 December 2020

Proteoglycans in atherosclerosis and restenosis: key roles for versican

1 reference

12 December 2020

Properties of lipoprotein complexes isolated by affinity chromatography from human aorta

1 reference

12 December 2020

Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin

1 reference

12 December 2020

Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions

1 reference

12 December 2020

Acute inflammation increases selective uptake of HDL cholesteryl esters into adrenals of mice overexpressing human sPLA2.

1 reference

12 December 2020

George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry.

1 reference

12 December 2020

Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice

1 reference

12 December 2020

Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins: a mechanism for atherogenic lipid accumulation

1 reference

12 December 2020

Inflammation, atherosclerosis, and coronary artery disease

1 reference

12 December 2020

Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2.

1 reference

12 December 2020

Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress

1 reference

12 December 2020

A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains

1 reference

12 December 2020

Identification of Apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans

1 reference

12 December 2020

Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I

1 reference

12 December 2020

The mortality of rheumatoid arthritis

1 reference

12 December 2020

Lipolysis of LDL by Human Secretory Phospholipase A 2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans

1 reference

12 December 2020

Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.

1 reference

12 December 2020

Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study

1 reference

12 December 2020

Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis

1 reference

12 December 2020

Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.

1 reference

12 December 2020

High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease

1 reference

12 December 2020

Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques

1 reference

12 December 2020

Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet

1 reference

12 December 2020

Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation

1 reference

12 December 2020

Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study

1 reference

12 December 2020

Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids.

1 reference

12 December 2020

Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall

1 reference

12 December 2020

Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

1 reference

12 December 2020

Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins

1 reference

12 December 2020

10.1007/S11883-008-0039-6

Identifiers

DOI

1 reference

18 August 2017

1 reference